Effect of beta blocker in treatment of paroxysmal atrial fibrillation:a meta-analysis
Shujuan ZHANG,Qingyan ZHAO,Zixuan DAI,Xiaozhan WANG,Zongwen GUO,Hongyi ZHAO
DOI: https://doi.org/10.3969/j.issn.1671-6450.2015.07.019
2015-01-01
Abstract:Objective To assess the efficacy and safety of beta blockers in the treatment of paroxysmal atrial fibrilla-tion.Method From 2001 January to 2014 September, computer retrieval of controlled trials in the Cochrane library, PubMed database, Wanfang Data, Chinese academic periodical full-text database, VIP database ( VIP) , the clinical randomized con-trolled trials of beta blocker therapy in patients with paroxysmal atrial fibrillation ( RCT) were collected, 2 reviewers according to the inclusion and exclusion criteria, extracted the data independently, cross check and evaluate the quality of methodology, use RevMan 5 software to perform the Meta-analysis.Result 26 studies of 3368 cases were included.(1) combined with the application of beta blocker therapy in patients with paroxysmal atrial fibrillation was better than amiodarone (OR=1.97, 95%CI 1.49~2.61, P <0.05), Wenxin Granule (OR=1.37, 95%CI 0.69~4.81 P <0.05), and ACEI (OR=2.29, 95%CI 1.53~3.43, P <0.05), the total effective rate of treatment group was higher than that of control group (OR=2.06, 95%CI 1.73 ~2.45, P <0.05); (2) the security: the gastrointestinal adverse reaction rate: the combined use of beta blockers significantly has lower adverse reaction rate than amiodarone alone (OR=0.39, 95% CI 0.22~0.69, P <0.05) and Wenxin Granules (OR=0.24, 95%CI 0.06 ~0.88, P <0.05), with no significant difference compared with ACEI drugs (OR=0.50, 95%CI 0.24~1.06, P >0.05), the overall induced gastrointestinal adverse reaction rate was lower than the control group (OR=0.48, 95%CI, 0.35~0.66, P <0.05).Adverse drug reactions induced by arrhythmia rate was lower than the single application of Wenxin Granules (OR=0.23, 95%CI 0.06~0.96, P <0.05), compared with amioda-rone (OR=0.59, 95%CI 0.35~1.00, P >=0.05) and ACEI (OR=0.62, 95%CI 0.37~1.04, P >=0.05) showed no significant difference;the overall adverse reaction induced by arrhythmia rate the treatment group was lower than that of control group (OR=0 .60, 95%CI, 0.46~0.79, P <0.05).Conclusion Beta blockers has good clinical efficacy in the treatment of paroxysmal atrial fibrillation with low incidence rate of adverse reaction.Limited with the quality of the included studies, the evaluation of the treatment of paroxysmal atrial fibrillation efficacy and safety need more high quality randomized controlled double-blind trial.